Literature DB >> 24839219

Rebuttal to "ezetimibe treatment should be considered for patients with sitosterolemia".

Elif Erkan1.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 24839219     DOI： 10.1007/s00467-014-2844-1

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN： 0931-041X            Impact factor:   3.714


× No keyword cloud information.
  3 in total

1.  Ezetimibe treatment should be considered for patients with sitosterolemia.

Authors:  Miao Hu; Brian Tomlinson
Journal:  Pediatr Nephrol       Date:  2014-05-17       Impact factor: 3.714

2.  Ezetimibe effectively reduces plasma plant sterols in patients with sitosterolemia.

Authors:  G Salen; K von Bergmann; D Lütjohann; P Kwiterovich; J Kane; S B Patel; T Musliner; P Stein; B Musser
Journal:  Circulation       Date:  2004-02-09       Impact factor: 29.690

3.  Atherosclerotic renal artery stenosis as a cause for hypertension in an adolescent patient.

Authors:  Tennille N Webb; Mohun Ramratnam; Rhobert W Evans; Trevor Orchard; John Pacella; Elif Erkan
Journal:  Pediatr Nephrol       Date:  2014-02-16       Impact factor: 3.714
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.